Histone Deacetylase 3 Coordinates Heart Development Through Stage-Specific Roles in Cardiac Progenitor Cells
Authors
Lewandowski, Sara L.Faculty Advisor
Chinmay TrivediAcademic Program
Translational ScienceUMass Chan Affiliations
Cardiovascular MedicineDocument Type
Doctoral DissertationPublication Date
2016-12-21Keywords
Hdac3histone deacetylase
cardiac development
heart
congenital heart disease
primary heart field
second heart field
progenitor cells
development
chromatin
epigenetics
gene regulation
Tbx5
Tgf-beta
Cell and Developmental Biology
Cell Biology
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Developmental Biology
Molecular Genetics
Metadata
Show full item recordAbstract
Disruptions in cardiac development cause congenital heart disease, the most prevalent and deadly congenital malformation. Genetic and environmental factors are thought to contribute to these defects, however molecular mechanisms remain largely undefined. Recent work highlighted potential roles of chromatin- modifying enzymes in congenital heart disease pathogenesis. Histone deacetylases, a class of chromatin-modifying enzymes, have developmental importance and recognized roles in the mature heart. This thesis aimed to characterize functions of Hdac3 in cardiac development. We found loss of Hdac3 in the primary heart field causes precocious progenitor cell differentiation, resulting in hypoplastic ventricular walls, ventricular septal defect, and mid- gestational lethality. In primary heart field progenitors, Hdac3 interacts with, deacetylates, and functionally suppresses transcription factor Tbx5. Furthermore, a disease-associated Tbx5 mutation disrupts this interaction, rendering Tbx5 hyperacetylated and hyperactive. By contrast, deletion of Hdac3 in second heart field progenitors bypasses these defects, instead causing malformations in the outflow tract and semilunar valves, with lethality prior to birth. Affected semilunar valves and outflow tract vessels exhibit extracellular matrix and EndMT defects and activation of the Tgfβ1 signaling pathway. In normal second heart field development, Hdac3 represses Tgfβ1 transcription, independent of its deacetylase activity, by recruiting the PRC2 methyltransferase complex to methylate the Tgfβ1 promoter. Importantly, knockouts of Hdac3 in differentiated cardiac cells do not fully recapitulate the progenitor-specific knockout phenotypes. These results illustrate spatiotemporal roles of Hdac3, both deacetylase-dependent and deacetylase-independent, in cardiac development, suggesting that dysregulation of Hdac3 in cardiac progenitor cells could be a contributing factor in congenital heart disease pathogenesis.DOI
10.13028/M26P4DPermanent Link to this Item
http://hdl.handle.net/20.500.14038/32260Rights
Licensed under a Creative Commons licenseDistribution License
http://creativecommons.org/licenses/by/4.0/ae974a485f413a2113503eed53cd6c53
10.13028/M26P4D
Scopus Count
Except where otherwise noted, this item's license is described as Licensed under a Creative Commons license
Related items
Showing items related by title, author, creator and subject.
-
Response of the right ventricle to exercise in patients with chronic heart diseaseWeiner, Bonnie H.; Alpert, Joseph S.; Dalen, James E.; Ockene, Ira S. (1983-03-01)The response of the right ventricle to exercise was examined in 19 patients with heart disease by constructing right ventricular function curves and determining the relationship between right ventricular afterload and preload. Simultaneous cardiac output and right heart pressures were measured at rest, during exercise, and 10 minutes after exercise. The patients were divided into two groups: those in whom the mean right atrial pressure did not rise above 7 mm Hg during exercise (group I, nine patients) and those in whom this variable did rise above 7 mm Hg (group II, 10 patients). A normal range for right ventricular function curves was derived from data reported in the literature. All of the patients in group I remained within this normal range during exercise. Half the patients in group II, however, fell outside the normal range during exercise. For all 19 patients, a linear relationship existed between right ventricular preload and afterload during exercise with a correlation between right atrial mean pressure and pulmonary arterial systolic pressure of r = 0.86.
-
Third-degree heart block complicating supraclavicular brachial plexus blockVyas, Anil; O'Connell, Frank M.; Vacanti, Charles A. (1996-09-01)Regional anesthesia is frequently administered to elderly patients and those with known cardiovascular disease in the hope of minimizing the cardiovascular complications associated with general anesthesia. Drug interactions between local anesthetics used in regional techniques and calcium channel blockers have been described. To date, however, potentially life-threatening dysrhythmias associated with brachial plexus blockade using the supraclavicular approach have not been reported. We now describe such a case.
-
Venous thromboembolism in heart failure: preventable deaths during and after hospitalizationPiazza, Gregory; Goldhaber, Samuel Z.; Lessard, Darleen M.; Goldberg, Robert J.; Emery, Catherine; Spencer, Frederick A. (2011-03-09)OBJECTIVE: Our aim was to compare the clinical characteristics, prophylaxis, treatment, and outcomes of patients with venous thromboembolism with and without heart failure. METHODS: We studied patients with heart failure in the population-based Worcester Venous Thromboembolism Study of 1822 consecutive patients with validated venous thromboembolism. RESULTS: Of the 1822 patients with venous thromboembolism, 319 (17.5%) had a history of clinical heart failure and 1503 (82.5%) did not. Patients with heart failure were older (mean age 75 vs 62 years, P<.0001) and more likely to have been immobilized (65.2% vs 46.1%, P<.0001). Thromboprophylaxis was omitted in approximately one third of patients with heart failure who had been hospitalized for non-venous thromboembolism-related illness or had undergone major surgery within the 3 months before diagnosis. Patients with heart failure had a higher frequency of in-hospital death (9.7% vs 3.3%, P<.0001) and death within 30 days of venous thromboembolism diagnosis (15.6% vs 6.4%, P<.0001). Heart failure (adjusted odds ratio [OR] 2.04; 95% confidence interval [CI], 1.15-3.62) and immobility (adjusted OR 4.37; 95% CI, 2.42-7.9) were associated with an increased risk of in-hospital death. Heart failure (adjusted OR 1.57; 95% CI, 1.01-2.43) and immobility (adjusted OR 3.05; 95% CI, 2.01-4.62) also were independent predictors of death within 30 days of venous thromboembolism diagnosis. CONCLUSION: High mortality was observed among patients with heart failure and venous thromboembolism both during and after hospitalization. Heart failure and immobility are potent risk factors for in-hospital death and death within 30 days in patients with venous thromboembolism.

